In vivo activation of SMN in spinal muscular atrophy carriers and patients treated with valproate
- 10 April 2006
- journal article
- clinical trial
- Published by Wiley in Annals of Neurology
- Vol. 59 (6) , 970-975
- https://doi.org/10.1002/ana.20836
Abstract
Objective Spinal muscular atrophy results from loss of the survival motor neuron 1 (SMN1) gene and malfunction of the remaining SMN2. We investigated whether valproic acid can elevate human SMN expression in vivo. Methods Blood was collected from 10 spinal muscular atrophy carriers and 20 spinal muscular atrophy patients treated with valproic acid. Results Seven of 10 carriers demonstrated increased SMN messenger RNA and protein levels. SMN2 messenger RNA levels were elevated in 7 patients and unchanged or decreased in 13 patients. Interpretation We provide first proof of the in vivo activation of a causative gene by valproic acid in an inherited disease and discuss strategies of monitoring drug response in patients.Keywords
This publication has 20 references indexed in Scilit:
- Determinants of Exon 7 Splicing in the Spinal Muscular Atrophy Genes, SMN1 and SMN2American Journal of Human Genetics, 2006
- SMNΔ7, the major product of the centromeric survival motor neuron (SMN2) gene, extends survival in mice with spinal muscular atrophy and associates with full-length SMNHuman Molecular Genetics, 2005
- Phenylbutyrate increases SMN gene expression in spinal muscular atrophy patientsEuropean Journal of Human Genetics, 2004
- Valproic acid increases SMN levels in spinal muscular atrophy patient cellsAnnals of Neurology, 2003
- Phenylbutyrate increases SMN expression in vitro: relevance for treatment of spinal muscular atrophyEuropean Journal of Human Genetics, 2003
- Valproic acid increases the SMN2 protein level: a well-known drug as a potential therapy for spinal muscular atrophyHuman Molecular Genetics, 2003
- Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assaysJournal of Molecular Endocrinology, 2000
- SMN oligomerization defect correlates with spinal muscular atrophy severityNature Genetics, 1998
- Identification and characterization of a spinal muscular atrophy-determining geneCell, 1995
- Incidence, prevalence, and gene frequency studies of chronic childhood spinal muscular atrophy.Journal of Medical Genetics, 1978